AstraZeneca, Alchemia sign $240 mn drug deal

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 23 Apr, 2013

Singapore: Alchemia signed a multi-target, drug discovery collaboration with AstraZeneca. The collaboration includes the...Read more

Victoria court approves Biota's merger with Nabi Biopharma

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 02 Nov, 2012

Singapore: The Supreme Court of Victoria has approved the scheme of arrangement between Biota Holdings and the holders o...Read more

Eisai gets approval for Halaven in Australia

Australia |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2012

Singapore: Eisai Australia, a subsidiary of the Japanese firm Eisai, has received approval from the Australian Departme...Read more

GI Dynamics starts US trial of EndoBarrier

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jan, 2013

Singapore: GI Dynamics has initiated its US multicenter pivotal clinical trial of EndoBarrier, the Endo trial, for the ...Read more

Pharmaxis for Prix Galien UK award

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jul, 2014

Singapore: Six companies have been short listed for this year's internationally recognised Prix Galien award UK Orphan D...Read more

Genome of extinct frog revived for fresh egg

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

Singapore: The genome of an extinct Australian frog has been revived and reactivated by a team of scientists using sophi...Read more

Protagonist, Ironwood expand peptide R&D deal

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 21 Dec, 2012

Singapore: US-based Protagonist Therapeutics and Australia-based Ironwood Pharmaceuticals expanded their research collab...Read more

Luminex restructures, shuts down Australian office

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 12 Aug, 2013

Singapore: Luminex entered a restructuring plan focused on its assay and related products (ARP) segment's newborn screen...Read more

Lonza produces Bionomics' stem cell cancer drug

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 25 Apr, 2013

Singapore: Bionomics has initiated manufacturing activities for BNC101, its lead anti-cancer stem cell candidate followi...Read more

Irish firm's track-&-trace system to curb fake drugs

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

Singapore: Horizon, an Irish engineerng consultancy firm, has completed testing of its new tracking system that aims at ...Read more

iSonea launches asthma monitoring device in Australia

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Sep, 2013

Singapore: Australian medical technology company, iSonea, launched AirSonea wheeze monitoring device, in the Australian ...Read more

Will the next blockbuster emerge from Asia?

Australia |  Opinion | By Nandita Singh | 0 Comment | 17 Oct, 2012

Blockbusters and super profits. Will the bioscience industry in this decade see these words come to life? More important...Read more

One compound to kill all known malarial strains

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

Singapore: A recently discovered compound from the aminopyridine class could be a potential single-dose cure for all str...Read more

Bionomics seeks $4.2 mn R&D tax incentive

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jan, 2013

Singapore: Bionomics has lodged its FY 2012 tax return and registered with AusIndustry (on behalf of Innovation Austral...Read more

Indian, Australian science academies sign MoU

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 05 Dec, 2012

Singapore: The Australian Academy of Science (AAS) and Indian National Academy of Science (INAS) renewed their commitme...Read more

Bionomics acquires US cancer firm

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2012

Singapore: Adelaide-based biotechnology company Bionomics has strengthened its presence in the US with the acquisition o...Read more

Hettich, LBT form landmark bio-software JV

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

Singapore: Medical technology company, LBT Innovations, signed a landmark agreement with Switzerland-based laboratory in...Read more

Spinifex phase II postherpetic neuralgia trial is a success

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2012

Singapore: Spinifex Pharmaceuticals, an Australian pain drug development company, revealed positive headline results fr...Read more